Minmin Shi Selected Research

Minmin Shi Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 10/2014
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2016
6	Adenocarcinoma 01/2022 - 01/2017
6	Carcinogenesis 09/2019 - 10/2014
5	Inflammation (Inflammations) 09/2022 - 01/2014
4	Neoplasm Metastasis (Metastasis) 06/2019 - 10/2016
3	Reperfusion Injury 01/2021 - 01/2014
3	Esophageal Squamous Cell Carcinoma 01/2021 - 07/2013
2	Fibrosis (Cirrhosis) 09/2022 - 01/2014
2	Lymphatic Metastasis 01/2021 - 12/2017
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 07/2013
2	Colorectal Neoplasms (Colorectal Cancer) 09/2019 - 10/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2017 - 01/2014
2	Carcinoma (Carcinomatosis) 05/2017 - 01/2017
2	Portal Hypertension 01/2016 - 01/2014
1	Acute Lung Injury 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2022
1	Hypoxia (Hypoxemia) 06/2022
1	Ischemia 01/2021
1	Necrosis 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2019
1	Anaplastic Thyroid Carcinoma 10/2018
1	Liver Diseases (Liver Disease) 11/2017
1	Immune System Diseases (Immune Disorders) 01/2017
1	Lung Neoplasms (Lung Cancer) 05/2016
1	Primitive Neuroectodermal Tumors (PNET) 01/2016
1	Splenomegaly 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2014
7	Long Noncoding RNAIBA 01/2022 - 11/2016
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2016
3	Cyclin D1IBA 05/2017 - 01/2014
2	Beclin-1IBA 01/2021 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 05/2019 - 01/2019
2	Melitten (Melittin)IBA 01/2018 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2017
2	Gemcitabine FDA Link 01/2017 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 01/2016 - 01/2014
1	ACT001IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	ChromatinIBA 06/2022
1	folfirinoxIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Transfer RNA (tRNA)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 09/2019
1	NucleotidesIBA 09/2019
1	WD repeat containing planar cell polarity effectorIBA 08/2019
1	DNA (Deoxyribonucleic Acid)IBA 08/2019
1	CateninsIBA 08/2019
1	p38 Mitogen-Activated Protein KinasesIBA 02/2019
1	Small Nucleolar RNA (snoRNA)IBA 01/2019
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 10/2018
1	apatinibIBA 10/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2018
1	VimentinIBA 08/2018
1	Cadherins (E-Cadherin)IBA 08/2018
1	Retinoblastoma-Like Protein p130IBA 01/2018
1	Therapeutic UsesIBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	Caffeine (No Doz)FDA LinkGeneric 11/2017
1	CholesterolIBA 01/2017
1	AgarIBA 11/2016
1	Nerve Growth Factors (Neurotrophins)IBA 10/2016
1	src-Family KinasesIBA 10/2016
1	Growth Factor ReceptorsIBA 10/2016
1	CortactinIBA 10/2016
1	Monoclonal AntibodiesIBA 05/2016
1	glucose-regulated proteinsIBA 01/2016
1	NucleophosminIBA 08/2015
1	JNK Mitogen-Activated Protein KinasesIBA 01/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2013

Therapy/Procedure

4	Therapeutics 01/2017 - 01/2014
2	Adjuvant Chemotherapy 01/2021 - 07/2013
2	Ligation 01/2016 - 01/2014
1	Aftercare (After-Treatment) 06/2019
1	Pancreatectomy 06/2019
1	Laparotomy 06/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017